Original Research

Published on 27 Jan 2022

Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat

in Psychopharmacology

Christien Bowman
Ulrike Richter
Christopher R. Jones
Claus Agerskov
Kjartan Frisch Herrik

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.737295

5,137 views
5 citations

Review

Published on 25 Jan 2022

Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?

in Psychopharmacology

Pavel Mohr
Jirí Masopust
Miloslav Kopeček

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.781946

30,603 views
24 citations

Original Research

Published on 24 Jan 2022

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database

in Psychopharmacology

Tigran Makunts
Lisa Jerome
Ruben Abagyan
Alberdina de Boer

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.824288

36,143 views
13 citations

Original Research

Published on 24 Jan 2022

Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study)

in Psychopharmacology

Stanislav V. Ivanov
Anatoly B. Smulevich
Evgeniya I. Voronova
Kausar K. Yakhin
Tangyul Z. Beybalaeva
Alena A. Katok

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.770592

2,513 views
7 citations

Original Research

Published on 19 Jan 2022

The Cognitive-Enhancing Effects of Dendrobium nobile Lindl Extract in Sleep Deprivation-Induced Amnesic Mice

in Psychopharmacology

Ning Jiang
Yu-jiao Li
Meng-di Wang
Hong Huang
Shanguang Chen
Yinghui Li
Lina Qu
Fengzhong Wang
Xinmin Liu
Qiong Wang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.596017

3,530 views
5 citations

Case Report

Published on 12 Jan 2022

A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression

in Psychopharmacology

Shannon Dames
Pamela Kryskow
Crosbie Watler

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.803279

19,838 views
19 citations

Original Research

Published on 12 Jan 2022

Effects of Acceptance and Commitment Therapy and Repetitive Transcranial Magnetic Stimulation on Obsessive–Compulsive Disorder

in Psychopharmacology

Jingzhi Zou
Siliang Wu
Xin Yuan
Zhizhong Hu
Jun Tang
Maorong Hu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.720518

4,490 views
3 citations

Original Research

Published on 12 Jan 2022

Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D3 Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders

in Psychopharmacology

Jan Kehr
Fu-Hua Wang
Fumio Ichinose
Shimako Yoshitake
Bence Farkas
Béla Kiss
Nika Adham

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.801641

4,498 views
3 citations

Perspective

Published on 05 Jan 2022

Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia

in Psychopharmacology

Elmars Rancans
Zsófia Borbála Dombi
Ágota Barabássy

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.770234

10,945 views
12 citations

Review

Published on 03 Jan 2022

Primary and Secondary Negative Symptoms in Schizophrenia

in Psychopharmacology

Sergey N. Mosolov
Polina A. Yaltonskaya

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.766692

60,782 views
65 citations

Correction

Published on 21 Dec 2021

Corrigendum: Risk of Bleeding Associated With Antidepressants: Impact of Causality Assessment and Competition Bias on Signal Detection

in Psychopharmacology

René Zeiss
Bernhard J. Connemann
Carlos Schönfeldt-Lecuona
Maximilian Gahr

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.813879

1,163 views
1 citation

Review

Published on 17 Dec 2021

Protective Effects and Mechanism of Radix Polygalae Against Neurological Diseases as Well as Effective Substance

in Psychopharmacology

Ning Jiang
Shanshan Wei
Yiwen Zhang
Wenlu He
Haiyue Pei
Hong Huang
Qiong Wang
Xinmin Liu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.688703

10,709 views
18 citations

Review

Published on 17 Dec 2021

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder

in Psychopharmacology

Amber N. Edinoff
Haseeb A. Akuly
John H. Wagner
Megan A. Boudreaux
Leah A. Kaplan
Shadman Yusuf
Elisa E. Neuchat
Elyse M. Cornett
Andrea G. Boyer
Adam M. Kaye

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.789982

23,189 views
16 citations

Case Report

Published on 16 Dec 2021

Cariprazine Use in Early Psychosis: Three Case Reports

in Psychopharmacology

Ricardo Coentre
Rodrigo Saraiva
Carolina Sereijo
Pedro Levy

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.788281

3,745 views
4 citations

Original Research

Published on 16 Dec 2021

The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study

in Psychopharmacology

Andrea Aguglia
Laura Fusar-Poli
Andrea Amerio
Valeria Placenti
Carmen Concerto
Giovanni Martinotti
Giuseppe Carrà
Francesco Bartoli
Armando D'Agostino
Gianluca Serafini

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.784366

3,858 views
4 citations

Perspective

Published on 16 Dec 2021

Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia

in Psychopharmacology

Lola Peris
Nestor Szerman

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.769623

4,895 views
9 citations

Navigation group

Articles

Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat

Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database

Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study)

The Cognitive-Enhancing Effects of Dendrobium nobile Lindl Extract in Sleep Deprivation-Induced Amnesic Mice

A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression

Effects of Acceptance and Commitment Therapy and Repetitive Transcranial Magnetic Stimulation on Obsessive–Compulsive Disorder

Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D3 Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders

Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia

Primary and Secondary Negative Symptoms in Schizophrenia

Corrigendum: Risk of Bleeding Associated With Antidepressants: Impact of Causality Assessment and Competition Bias on Signal Detection

Protective Effects and Mechanism of Radix Polygalae Against Neurological Diseases as Well as Effective Substance

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder

Cariprazine Use in Early Psychosis: Three Case Reports

The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study

Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia